US customs seize 100k fake N95s from Hong Kong
US customs officials at John F Kennedy International Airport in New York have seized 100,000 counterfeit 3M N95 masks imported from Hong Kong.
Lawyer opposes Allergan’s bid for interlocutory appeal in FCA suit
Allergan should not be permitted to immediately appeal against a recent ruling which requires it to face allegations that it monopolised the pricing of dementia drugs, according to a New York-based patent attorney.
CBD company faults sparse evidence in trade secrets spat
Medical cannabis company Medterra and has hit back at claims it misappropriated trade secrets at a federal court in Florida, holding that the company alleging the IP violation had failed to produce sufficient evidence.
Pfizer sues India generic drugmaker over cancer drug
Pharmaceutical company Pfizer has accused generic drug maker Aurobindo of infringement, as it attempts to block the roll-out of copies of its blockbuster arthritis drug, Xeljanz.
MSD sues Pfizer’s Wyeth over vaccine patents
Pharmaceutical company MSD has urged a federal court to rule that its new vaccine doesn’t infringe three patents owned by Pfizer’s subsidiary, Wyeth, because they are invalid.
EPA and OSHA to share secrets on workplace chemical exposure
Two federal agencies in the US have agreed to share confidential business information about the manufacture of chemicals that are produced and imported, in efforts to improve the protection of workers who may be exposed to a new chemical substance.
Illumina accused of fraud in DNA tech patents dispute
Illumina tried to secure its control over the DNA sequencing technology market by violating antitrust law, according to a suit by BGI Americas and two of its subsidiaries, at the US Court for the District Court of San Francisco.
Sanofi buys Kymab in boost to immunotherapy portfolio
Sanofi will buy British immunotherapy firm Kymab for up to $1.45 billion, as it seeks to expand in the rapidly growing immunotherapy field.
SCOTUS weighs future of assignor estoppel
The US Supreme Court will decide whether or not to maintain a legal doctrine which stops inventors who sell their patent rights from later claiming the patents are invalid.
Roche urges SCOTUS to cancel Illumina patent win
Roche has asked the US Supreme Court to declare that methods of separating DNA are not patent-eligible.
